22
Sirnaomics Ltd.
2257.HK · HKSE
$3.74 -0.27% (-$0.01)
1M -3.85%
Market Cap $51.8M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$4.1
9.8% upside
Current Price
$3.74
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 2257.HK is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/FFO N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
57 /100
Average ROIC 101.29%
ROA 70.01%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.40x
Int. coverage -18.90x
Debt/Equity N/A
Stability
32 /100
Unstable Beta -0.04x
Rev. volatility 243.95%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 2257.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Hung Fai Poon
Employees
37
Headquarters
Germantown
Upcoming events
01 APR
Earnings
Upcoming earnings report